Recurrent Angiomyofibroblastoma of the Vulva: MRI Characteristics and Long-Term Monitoring Insights.

Taiwan J Obstet GynecolOct 30, 2026

Kuang-Yen Lee, I-Lun Shih, Jen-Chieh Lee et al.

✦ AI-curated · Sources linked

Case in brief

A 33-year-old woman presented with a painless, pedunculated right vulvar mass, excised and diagnosed pathologically as angiomyofibroblastoma (AMFB). Follow-up pelvic CT showed a small irregular enhancing lesion at the site, and MRI later demonstrated a 6.1 × 4.8 × 2.8 cm heterogeneous tumor with T2 hyperintensity, marked post-contrast enhancement, and mild diffusion restriction. Excision confirmed recurrent AMFB. She remained free of recurrence for four years after the second operation.

What made this case unusual

The case documents recurrent vulvar AMFB with MRI features including heterogeneous signal, strong enhancement, and mild diffusion restriction.

Diagnostic / clinical pearl

A new enhancing vulvar lesion after AMFB excision may represent recurrence; MRI can characterize the lesion, with pathology confirming the diagnosis.

Why it matters

The report highlights MRI monitoring as an option for patients with recurrent AMFB who are concerned about repeated surgery.

Source

Published in Taiwan J Obstet Gynecol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Obstetrics & Gynecology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.